Trial Profile
Pharmacokinetics and glucodynamics of long-acting basal insulin peglispro in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Insulin peglispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 24 Nov 2015 New trial record